Work

Target Identification of Cytotoxic 1,4-Benzodiazepine-2,5-Diones

Year: 2011
Type: dissertation
Abstract: This study aims to elucidate the apoptotic target of cytotoxic 1,4-benzodiazepine-2,5diones.Previous studies have identified certain 1,4-benzodiazepine-2,5-diones as competitive ATP-binding site inhibitors of Rho-associated protein kinase (ROCK).Through sequence analysis of the ROCK ATP-binding cleft a novel potential apoptotic target, cell cycle related kinase (CCRK), was identified.CCRK is thought to activate cyclin dependent kinase 2 (CDK2) by phosphorylating Thr160.CDK2 in turn functions as a key cell cycle regulator of the G 1 to S cell cycle phase transition.We report here that cellular treatment with S-UM-BD-29, one such cytotoxic 1,4-benzodiazepine-2,5-dione, results in G 1 to S phase cell cycle arrest and a decrease in CDK2 phosphorylation.Furthermore, we report a robust relationship between differing natural protein levels of CCRK across cell lines and sensitivity to S-UM-BD-29.Additional in vitro kinase inhibition and siRNA CCRK knockdown experiments proved unsuccessful and definitive evidence that CCRK is the cellular target of cytotoxic 1,4-benzodiazepine-2,5-diones that induces apoptosis remains elusive.The findings reported here do suggest that CCRK is the likely target of cytotoxic 1,4-benzodiazepine-2,5-diones, though, and future research will serve to validate this.CCRK is quickly emerging as an important physiological target of certain cancers and a compound that is capable of treating cancer cells that rely on CCRK for survival has very promising therapeutic potential.
Language: English
Field: Chemistry
Open Access status: green
OpenAlex ID: W90008533
Cites: 25
Cited by:
Related to: 10